Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India

Background & objectives: Number of metastatic lymph nodes has a strong prognostic value in the course of breast cancer treatment, morbidity and mortality. This study was undertaken to determine the association between axillary lymph node metastasis and several variables such as age, tumour size,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of medical research (New Delhi, India : 1994) India : 1994), 2016-05, Vol.143 (7), p.45-51
Hauptverfasser: Chakraborty, Abhijit, Bose, Chinmoy, Basak, Jayasri, Sen, Aditya, Mishra, Raghwendra, Mukhopadhyay, Ashis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 51
container_issue 7
container_start_page 45
container_title Indian journal of medical research (New Delhi, India : 1994)
container_volume 143
creator Chakraborty, Abhijit
Bose, Chinmoy
Basak, Jayasri
Sen, Aditya
Mishra, Raghwendra
Mukhopadhyay, Ashis
description Background & objectives: Number of metastatic lymph nodes has a strong prognostic value in the course of breast cancer treatment, morbidity and mortality. This study was undertaken to determine the association between axillary lymph node metastasis and several variables such as age, tumour size, grade, lymphovascular invasion, oestrogen and progesterone receptor expression and HER2/neu status in patients with breast cancer. Methods: In this study 426 (with complete information on study variables) patients with breast cancer on treatment during March 2010 to December 2013, were analyzed. TNM (tumour node matastasis) staging was evaluated. The histological grading of tumours was done according to modified Bloom-Richardson Grading System. The immunophenotype of the tumour was determined as the expression of oestrogen (ER) and progesterone (PR) receptors and Her0 2/neu status. Univariate and multivariate analyses were carried out to determine the independent predictors of metastatic lymph node. Results: Among the studied patients, 44.36 per cent (189 of 426) of the patients had nodal metastases. t0 umour histology, tumour grade, size and lympho-vascular invasion were related with node positivity. On univariate analysis, age, menopause, hormone receptor status did not relate with the node metastasis. Age, tumour grade, tumour size, lympho-vascular invasion and HER2/neu expression was likely to be associated with the number of lymph node metastasis. Interpretation & conclusions: The lymph node status was associated with clinical stage, tumour grade, tumour histology and HER2/neu status. t0 hese factors may be used for better management of such patients.
doi_str_mv 10.4103/0971-5916.191761
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5080928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A467802113</galeid><sourcerecordid>A467802113</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549n-c318dbcb4b51ae0ff64ed72035662683199ffbd4e2abdb994f656530cf192b293</originalsourceid><addsrcrecordid>eNptksFvFCEUxuegsXX17smQePEyKzAwM3gw2VRtmzTxomcCzKNDOwMrzHSz_71Mtl27xpA8Evh9H3m8ryjeEbxmBFefsGhIyQWp10SQpiYvivPj0VnxOqU7jImgjXhVnNGmYW0u50X_FSaIo_PKTwkFi4b9uO2RDx2gNKlpTsh5tAsj5OqmHukIKk3IKG8gfkYb1Ie0dZMakFYJuiyauz2yMYxoASF6dO07p94UL60aErx93FfFr-_ffl5clTc_Lq8vNjel4Uz40lSk7bTRTHOiAFtbM-gaiite17RuKyKEtbpjQJXutBDM1rzmFTY296apqFbFl4PvdtYjdAb8FNUgt9GNKu5lUE6e3njXy9vwIDlusaBtNvj4aBDD7xnSJEeXDAyD8hDmJElbcVY1LJdV8eEf9C7M0ef2JKW8pZjXgv-lbtUA0nkb8rtmMZUbVjctpoRUmVr_h8qrg9GZ4MG6fH4iwAeBiSGlCPbYI8FySYRcxi-X8ctDIrLk_fO_OQqe4pCBzQHYhSGPLt0P8w6izOy9D7sT4_KZsWRcPuWo-gMJnse6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258205695</pqid></control><display><type>article</type><title>Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India</title><source>MEDLINE</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Chakraborty, Abhijit ; Bose, Chinmoy ; Basak, Jayasri ; Sen, Aditya ; Mishra, Raghwendra ; Mukhopadhyay, Ashis</creator><creatorcontrib>Chakraborty, Abhijit ; Bose, Chinmoy ; Basak, Jayasri ; Sen, Aditya ; Mishra, Raghwendra ; Mukhopadhyay, Ashis</creatorcontrib><description>Background &amp; objectives: Number of metastatic lymph nodes has a strong prognostic value in the course of breast cancer treatment, morbidity and mortality. This study was undertaken to determine the association between axillary lymph node metastasis and several variables such as age, tumour size, grade, lymphovascular invasion, oestrogen and progesterone receptor expression and HER2/neu status in patients with breast cancer. Methods: In this study 426 (with complete information on study variables) patients with breast cancer on treatment during March 2010 to December 2013, were analyzed. TNM (tumour node matastasis) staging was evaluated. The histological grading of tumours was done according to modified Bloom-Richardson Grading System. The immunophenotype of the tumour was determined as the expression of oestrogen (ER) and progesterone (PR) receptors and Her0 2/neu status. Univariate and multivariate analyses were carried out to determine the independent predictors of metastatic lymph node. Results: Among the studied patients, 44.36 per cent (189 of 426) of the patients had nodal metastases. t0 umour histology, tumour grade, size and lympho-vascular invasion were related with node positivity. On univariate analysis, age, menopause, hormone receptor status did not relate with the node metastasis. Age, tumour grade, tumour size, lympho-vascular invasion and HER2/neu expression was likely to be associated with the number of lymph node metastasis. Interpretation &amp; conclusions: The lymph node status was associated with clinical stage, tumour grade, tumour histology and HER2/neu status. t0 hese factors may be used for better management of such patients.</description><identifier>ISSN: 0971-5916</identifier><identifier>DOI: 10.4103/0971-5916.191761</identifier><identifier>PMID: 27748277</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Adult ; Age ; Aged ; Axilla - pathology ; Biology ; Biopsy ; Breast cancer ; Breast Neoplasms - epidemiology ; Breast Neoplasms - genetics ; Breast Neoplasms - pathology ; Cancer research ; Cancer therapies ; Chemotherapy ; Estrogen Receptor alpha - genetics ; Female ; Growth factors ; Histology ; Humans ; India - epidemiology ; Lymph Nodes - metabolism ; Lymph Nodes - pathology ; Lymphatic metastasis ; Lymphatic Metastasis - diagnosis ; Lymphatic Metastasis - pathology ; Lymphatic system ; Medical prognosis ; Metastasis ; Middle Aged ; Multivariate analysis ; Neoplasm Invasiveness - genetics ; Neoplasm Staging ; Original ; Ovarian cancer ; Prognosis ; Receptor, ErbB-2 - genetics ; Receptors, Progesterone - genetics ; Social aspects ; Studies ; Surgery ; Tumors ; Womens health</subject><ispartof>Indian journal of medical research (New Delhi, India : 1994), 2016-05, Vol.143 (7), p.45-51</ispartof><rights>COPYRIGHT 2016 Medknow Publications and Media Pvt. Ltd.</rights><rights>2016. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © Indian Journal of Medical Research 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549n-c318dbcb4b51ae0ff64ed72035662683199ffbd4e2abdb994f656530cf192b293</citedby><cites>FETCH-LOGICAL-c549n-c318dbcb4b51ae0ff64ed72035662683199ffbd4e2abdb994f656530cf192b293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080928/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080928/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27748277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chakraborty, Abhijit</creatorcontrib><creatorcontrib>Bose, Chinmoy</creatorcontrib><creatorcontrib>Basak, Jayasri</creatorcontrib><creatorcontrib>Sen, Aditya</creatorcontrib><creatorcontrib>Mishra, Raghwendra</creatorcontrib><creatorcontrib>Mukhopadhyay, Ashis</creatorcontrib><title>Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India</title><title>Indian journal of medical research (New Delhi, India : 1994)</title><addtitle>Indian J Med Res</addtitle><description>Background &amp; objectives: Number of metastatic lymph nodes has a strong prognostic value in the course of breast cancer treatment, morbidity and mortality. This study was undertaken to determine the association between axillary lymph node metastasis and several variables such as age, tumour size, grade, lymphovascular invasion, oestrogen and progesterone receptor expression and HER2/neu status in patients with breast cancer. Methods: In this study 426 (with complete information on study variables) patients with breast cancer on treatment during March 2010 to December 2013, were analyzed. TNM (tumour node matastasis) staging was evaluated. The histological grading of tumours was done according to modified Bloom-Richardson Grading System. The immunophenotype of the tumour was determined as the expression of oestrogen (ER) and progesterone (PR) receptors and Her0 2/neu status. Univariate and multivariate analyses were carried out to determine the independent predictors of metastatic lymph node. Results: Among the studied patients, 44.36 per cent (189 of 426) of the patients had nodal metastases. t0 umour histology, tumour grade, size and lympho-vascular invasion were related with node positivity. On univariate analysis, age, menopause, hormone receptor status did not relate with the node metastasis. Age, tumour grade, tumour size, lympho-vascular invasion and HER2/neu expression was likely to be associated with the number of lymph node metastasis. Interpretation &amp; conclusions: The lymph node status was associated with clinical stage, tumour grade, tumour histology and HER2/neu status. t0 hese factors may be used for better management of such patients.</description><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Axilla - pathology</subject><subject>Biology</subject><subject>Biopsy</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer research</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Estrogen Receptor alpha - genetics</subject><subject>Female</subject><subject>Growth factors</subject><subject>Histology</subject><subject>Humans</subject><subject>India - epidemiology</subject><subject>Lymph Nodes - metabolism</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphatic metastasis</subject><subject>Lymphatic Metastasis - diagnosis</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Lymphatic system</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Multivariate analysis</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neoplasm Staging</subject><subject>Original</subject><subject>Ovarian cancer</subject><subject>Prognosis</subject><subject>Receptor, ErbB-2 - genetics</subject><subject>Receptors, Progesterone - genetics</subject><subject>Social aspects</subject><subject>Studies</subject><subject>Surgery</subject><subject>Tumors</subject><subject>Womens health</subject><issn>0971-5916</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptksFvFCEUxuegsXX17smQePEyKzAwM3gw2VRtmzTxomcCzKNDOwMrzHSz_71Mtl27xpA8Evh9H3m8ryjeEbxmBFefsGhIyQWp10SQpiYvivPj0VnxOqU7jImgjXhVnNGmYW0u50X_FSaIo_PKTwkFi4b9uO2RDx2gNKlpTsh5tAsj5OqmHukIKk3IKG8gfkYb1Ie0dZMakFYJuiyauz2yMYxoASF6dO07p94UL60aErx93FfFr-_ffl5clTc_Lq8vNjel4Uz40lSk7bTRTHOiAFtbM-gaiite17RuKyKEtbpjQJXutBDM1rzmFTY296apqFbFl4PvdtYjdAb8FNUgt9GNKu5lUE6e3njXy9vwIDlusaBtNvj4aBDD7xnSJEeXDAyD8hDmJElbcVY1LJdV8eEf9C7M0ef2JKW8pZjXgv-lbtUA0nkb8rtmMZUbVjctpoRUmVr_h8qrg9GZ4MG6fH4iwAeBiSGlCPbYI8FySYRcxi-X8ctDIrLk_fO_OQqe4pCBzQHYhSGPLt0P8w6izOy9D7sT4_KZsWRcPuWo-gMJnse6</recordid><startdate>20160501</startdate><enddate>20160501</enddate><creator>Chakraborty, Abhijit</creator><creator>Bose, Chinmoy</creator><creator>Basak, Jayasri</creator><creator>Sen, Aditya</creator><creator>Mishra, Raghwendra</creator><creator>Mukhopadhyay, Ashis</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Scientific Scholar</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160501</creationdate><title>Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India</title><author>Chakraborty, Abhijit ; Bose, Chinmoy ; Basak, Jayasri ; Sen, Aditya ; Mishra, Raghwendra ; Mukhopadhyay, Ashis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549n-c318dbcb4b51ae0ff64ed72035662683199ffbd4e2abdb994f656530cf192b293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Axilla - pathology</topic><topic>Biology</topic><topic>Biopsy</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer research</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Estrogen Receptor alpha - genetics</topic><topic>Female</topic><topic>Growth factors</topic><topic>Histology</topic><topic>Humans</topic><topic>India - epidemiology</topic><topic>Lymph Nodes - metabolism</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphatic metastasis</topic><topic>Lymphatic Metastasis - diagnosis</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Lymphatic system</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Multivariate analysis</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neoplasm Staging</topic><topic>Original</topic><topic>Ovarian cancer</topic><topic>Prognosis</topic><topic>Receptor, ErbB-2 - genetics</topic><topic>Receptors, Progesterone - genetics</topic><topic>Social aspects</topic><topic>Studies</topic><topic>Surgery</topic><topic>Tumors</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chakraborty, Abhijit</creatorcontrib><creatorcontrib>Bose, Chinmoy</creatorcontrib><creatorcontrib>Basak, Jayasri</creatorcontrib><creatorcontrib>Sen, Aditya</creatorcontrib><creatorcontrib>Mishra, Raghwendra</creatorcontrib><creatorcontrib>Mukhopadhyay, Ashis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of medical research (New Delhi, India : 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chakraborty, Abhijit</au><au>Bose, Chinmoy</au><au>Basak, Jayasri</au><au>Sen, Aditya</au><au>Mishra, Raghwendra</au><au>Mukhopadhyay, Ashis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India</atitle><jtitle>Indian journal of medical research (New Delhi, India : 1994)</jtitle><addtitle>Indian J Med Res</addtitle><date>2016-05-01</date><risdate>2016</risdate><volume>143</volume><issue>7</issue><spage>45</spage><epage>51</epage><pages>45-51</pages><issn>0971-5916</issn><abstract>Background &amp; objectives: Number of metastatic lymph nodes has a strong prognostic value in the course of breast cancer treatment, morbidity and mortality. This study was undertaken to determine the association between axillary lymph node metastasis and several variables such as age, tumour size, grade, lymphovascular invasion, oestrogen and progesterone receptor expression and HER2/neu status in patients with breast cancer. Methods: In this study 426 (with complete information on study variables) patients with breast cancer on treatment during March 2010 to December 2013, were analyzed. TNM (tumour node matastasis) staging was evaluated. The histological grading of tumours was done according to modified Bloom-Richardson Grading System. The immunophenotype of the tumour was determined as the expression of oestrogen (ER) and progesterone (PR) receptors and Her0 2/neu status. Univariate and multivariate analyses were carried out to determine the independent predictors of metastatic lymph node. Results: Among the studied patients, 44.36 per cent (189 of 426) of the patients had nodal metastases. t0 umour histology, tumour grade, size and lympho-vascular invasion were related with node positivity. On univariate analysis, age, menopause, hormone receptor status did not relate with the node metastasis. Age, tumour grade, tumour size, lympho-vascular invasion and HER2/neu expression was likely to be associated with the number of lymph node metastasis. Interpretation &amp; conclusions: The lymph node status was associated with clinical stage, tumour grade, tumour histology and HER2/neu status. t0 hese factors may be used for better management of such patients.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>27748277</pmid><doi>10.4103/0971-5916.191761</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0971-5916
ispartof Indian journal of medical research (New Delhi, India : 1994), 2016-05, Vol.143 (7), p.45-51
issn 0971-5916
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5080928
source MEDLINE; PubMed Central; PubMed Central Open Access
subjects Adult
Age
Aged
Axilla - pathology
Biology
Biopsy
Breast cancer
Breast Neoplasms - epidemiology
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Cancer research
Cancer therapies
Chemotherapy
Estrogen Receptor alpha - genetics
Female
Growth factors
Histology
Humans
India - epidemiology
Lymph Nodes - metabolism
Lymph Nodes - pathology
Lymphatic metastasis
Lymphatic Metastasis - diagnosis
Lymphatic Metastasis - pathology
Lymphatic system
Medical prognosis
Metastasis
Middle Aged
Multivariate analysis
Neoplasm Invasiveness - genetics
Neoplasm Staging
Original
Ovarian cancer
Prognosis
Receptor, ErbB-2 - genetics
Receptors, Progesterone - genetics
Social aspects
Studies
Surgery
Tumors
Womens health
title Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A05%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determinants%20of%20lymph%20node%20status%20in%20women%20with%20breast%20cancer:%20A%20hospital%20based%20study%20from%20eastern%20India&rft.jtitle=Indian%20journal%20of%20medical%20research%20(New%20Delhi,%20India%20:%201994)&rft.au=Chakraborty,%20Abhijit&rft.date=2016-05-01&rft.volume=143&rft.issue=7&rft.spage=45&rft.epage=51&rft.pages=45-51&rft.issn=0971-5916&rft_id=info:doi/10.4103/0971-5916.191761&rft_dat=%3Cgale_pubme%3EA467802113%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2258205695&rft_id=info:pmid/27748277&rft_galeid=A467802113&rfr_iscdi=true